| 4-Hydroxybenzoic acid derivatives as HDAC6-specific inhibitors modulating microtubular structure and HSP90α chaperone activity against prostate cancer C Seidel, M Schnekenburger, A Mazumder, MH Teiten, G Kirsch, M Dicato, ... Biochemical pharmacology 99, 31-52, 2016 | 94 | 2016 |
| Discovery and characterization of Isofistularin-3, a marine brominated alkaloid, as a new DNA demethylating agent inducing cell cycle arrest and sensitization to TRAIL in … C Florean, M Schnekenburger, JY Lee, KR Kim, A Mazumder, S Song, ... Oncotarget 7 (17), 24027, 2016 | 59 | 2016 |
| Natural scaffolds in anticancer therapy and precision medicine A Mazumder, C Cerella, M Diederich Biotechnology advances 36 (6), 1563-1585, 2018 | 41 | 2018 |
| Cardiac glycoside glucoevatromonoside induces cancer type-specific cell death NFZ Schneider, C Cerella, JY Lee, A Mazumder, KR Kim, A De Carvalho, ... Frontiers in pharmacology 9, 70, 2018 | 39 | 2018 |
| Bcl-2 protein family expression pattern determines synergistic pro-apoptotic effects of BH3 mimetics with hemisynthetic cardiac glycoside UNBS1450 in acute myeloid leukemia C Cerella, A Gaigneaux, A Mazumder, JY Lee, E Saland, F Radogna, ... Leukemia 31 (3), 755-759, 2017 | 32 | 2017 |
| Hydroxycoumarin OT-55 kills CML cells alone or in synergy with imatinib or Synribo: Involvement of ER stress and DAMP release A Mazumder, JY Lee, O Talhi, C Cerella, S Chateauvieux, A Gaigneaux, ... Cancer letters 438, 197-218, 2018 | 31 | 2018 |
| Tetrahydrobenzimidazole TMQ0153 triggers apoptosis, autophagy and necroptosis crosstalk in chronic myeloid leukemia S Song, JY Lee, L Ermolenko, A Mazumder, S Ji, H Ryu, HJ Kim, DW Kim, ... Cell death & disease 11 (2), 109, 2020 | 26 | 2020 |
| Discovery and Characterization of R/S-N-3-Cyanophenyl-N′-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New … M Schnekenburger, E Goffin, JY Lee, JY Jang, A Mazumder, S Ji, ... Journal of medicinal chemistry 60 (11), 4714-4733, 2017 | 24 | 2017 |
| Tubulin-binding anticancer polysulfides induce cell death via mitotic arrest and autophagic interference in colorectal cancer EY Efe, A Mazumder, JY Lee, A Gaigneaux, F Radogna, MJ Nasim, ... Cancer Letters 410, 139-157, 2017 | 23 | 2017 |
| The dialkyl resorcinol stemphol disrupts calcium homeostasis to trigger programmed immunogenic necrosis in cancer S Ji, JY Lee, J Schrör, A Mazumder, DM Jang, S Chateauvieux, ... Cancer letters 416, 109-123, 2018 | 21 | 2018 |
| Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells M Lernoux, M Schnekenburger, H Losson, K Vermeulen, H Hahn, ... Clinical Epigenetics 12, 1-26, 2020 | 18 | 2020 |
| Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer NB Punturi, S Seker, V Devarakonda, A Mazumder, R Kalra, CH Chen, ... Nature communications 12 (1), 2940, 2021 | 15 | 2021 |
| Preclinical assessment of the bioactivity of the anticancer coumarin OT48 by spheroids, colony formation assays, and zebrafish xenografts JY Lee, A Mazumder, M Diederich JoVE (Journal of Visualized Experiments), e57490, 2018 | 12 | 2018 |
| Preclinical assessment of the bioactivity of the anticancer coumarin OT48 by spheroids, colony formation assays, and zebrafish xenografts JY Lee, A Mazumder, M Diederich JoVE (Journal of Visualized Experiments), e57490, 2018 | 12 | 2018 |
| HER2 activation and endocrine treatment resistance in HER2-negative breast cancer A Mazumder, S Shiao, S Haricharan Endocrinology 162 (10), bqab153, 2021 | 11 | 2021 |
| Human telomerase reverse transcriptase depletion potentiates the growth-inhibitory activity of imatinib in chronic myeloid leukemia stem cells C Grandjenette, M Schnekenburger, A Gaigneaux, D Gerard, C Christov, ... Cancer Letters 469, 468-480, 2020 | 11 | 2020 |
| The DNA damage repair landscape in Black women with breast cancer A Mazumder, A Jimenez, RE Ellsworth, SJ Freedland, S George, ... Therapeutic advances in medical oncology 14, 17588359221075458, 2022 | 9 | 2022 |
| The HDAC6 inhibitor 7b induces BCR-ABL ubiquitination and downregulation and synergizes with imatinib to trigger apoptosis in chronic myeloid leukemia H Losson, SR Gajulapalli, M Lernoux, JY Lee, A Mazumder, D Gérard, ... Pharmacological Research 160, 105058, 2020 | 7 | 2020 |
| Cardiac glycoside glucoevatromonoside induces cancer type-specific cell death. Front Pharmacol 9: 70–70 NFZ Schneider, C Cerella, JY Lee, A Mazumder, KR Kim, A de Carvalho, ... | 4 | 2018 |
| Endocannabinoid dysfunction in neurological disease: neuro-ocular DAGLA-related syndrome MN Bainbridge, A Mazumder, D Ogasawara, R Abou Jamra, G Bernard, ... Brain 145 (10), 3383-3390, 2022 | 3 | 2022 |
